Novetats al fons de l'OMS: setembre de 2014
2014-09-19 13:05
|
|||||||||
|
| Política sanitària -- Europa | |||||||||||
|
|||||||||||
| - | |||||||||||
| Resum: | |||||||||||
| This study of 12 countries provides an overview of recent changes in national governments’ role in the governance of health systems, focusing on efforts to reconfigure responsibilities for health policy, regulation and management; the resultant policy priorities; and the initial impact. The shift in responsibilities shows little uniform direction: a number of countries have centralized certain areas of decision-making or regulation but decentralized others. The study reviews common trends, based on the country cases, and assesses potential future developments. | |||||||||||
| - | |||||||||||
| Malalties cròniques -- Prevenció | |||||||||
|
|||||||||
| - | |||||||||
| Resum: | |||||||||
| This study reviews for the first time the various national practices relating to clinical guidelines in 29 European countries (the European Union (EU), Norway and Switzerland). It shows that, while some have made impressive progress, many are still relying on sporadic and unclear processes. The level of sophistication, quality and transparency of guideline development varies substantially across the region, even when the system for producing guidelines is well established. There are nevertheless clear examples that – if shared – can assure and improve quality of care across Europe. | |||||||||
| - | |||||||||
| Aliments -- Contaminació | |||||||||||
|
|||||||||||
| - | |||||||||||
| Resum: | |||||||||||
| This report represents the conclusions of a Joint FAO/WHO Expert Committee convened to evaluate the safety of various food additives and a food contaminant with a view to concluding as to safety concerns and to preparing specifications for identity and purity. Annexed to the report are tables summarizing the Committee's recommendations for dietary exposures to and toxicological evaluations of the food additives and contaminant considered. | |||||||||||
| - | |||||||||||
| Indústria farmacèutica -- Control de qualitat | |||||||||||
|
|||||||||||
| - | |||||||||||
| Resum: | |||||||||||
| The following new guidelines were adopted and recommended for use, in addition to 20 monographs and general texts for inclusion in The International Pharmacopoeia and 11 new International Chemical Reference Substances. The International Pharmacopoeia – updating mechanism for the section on radiopharmaceuticals; WHO good manufacturing practices for pharmaceutical products: main principles; Model quality assurance system for procurement agencies; Assessment tool based on the model quality assurance system for procurement agencies: aide-memoire for inspection; Guidelines on submission of documentation for prequalification of finished pharmaceutical products approved by stringent regulatory authorities; and Guidelines on submission of documentation for a multisource (generic) finished pharmaceutical product: quality part. | |||||||||||
| - | |||||||||||
| © 2006 en endavant: Biblioteca del Departament de Salut |
———
Retorna
